Gene Query: RPUSD3

Dataset Description Geneva Score
A transcriptome-wide divergence in protein translation scales with LIN28B expression 22.19
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 21.11
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 20.56
Depicting early human development and germ cell origin with porcine embryos 20.3
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 18.72
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 18.39
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 18.39
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 15.08
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 14.48
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 14.06
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 13.86
Comprehensive comparative analysis of 5’ end RNA sequencing methods 12.47
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 11.45
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 11.45
Control of prostate tumour growth by the long non-coding RNA GHSROS 10.99
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 10.48
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 10.28
Impact of dieldrin on transcription in Jurkat T cells 10.22
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 10.14
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 10.06
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 9.92
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 9.79
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 9.33
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 9.2
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 8.8
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 8.78
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 8.45
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 8.44
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 8.26
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 7.93
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 7.89
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 7.88
Hijacking of stress response machinery by oncogenes in acute leukaemia 7.88
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 7.85
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 7.78
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 7.67
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 7.61
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 7.58
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 7.51
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 7.51
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 7.37
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 7.37
Survival of pancreatic cancer cells lacking KRAS function 7.07
Lysine benzoylation is a novel histone mark 6.97
Lysine benzoylation is a novel histone mark [RNA-seq] 6.97
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 6.71
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 6.7
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 6.67
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 6.53
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 6.53
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 6.49
Patient-derived luminal breast cancer xenografts with progestins 6.49
RNA expression analysis upon JMJD1C depletion 6.47
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 6.47
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 6.31
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 6.28
Mapping interactions for the TNIP2 hub protein 6.25
Human Treg NaCl stimulation 6.21
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 6.21
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 6.21
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 6.19
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 6.16
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 5.99
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 5.94
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 5.89
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 5.86
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 5.82
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 5.71
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 5.69
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 5.67
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 5.67
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 5.53
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 5.52
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 5.52
Generating Patterned Kidney Organoids for Studying Development and Diseases 5.48
NR2F2 study 5.47
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 5.47
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 5.46
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 5.46
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 5.42
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 5.41
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 5.34
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 5.33
RNA-seq analysis of uveal melanoma cells treated with FR900359 5.32
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 5.24
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 5.19
Identification of global regulators of T-helper cell lineage specification 5.19
Glioblastoma stem cells infected by ZIKA virus 5.18
CROP-Seq in Primary Human T Cells 5.17
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 5.16
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 5.16
Global analysis of enhancer targets: Mosaic-seq 5.08
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 5.07
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 4.99
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 4.95
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 4.9
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 4.89
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 4.84
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 4.75
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 4.65
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 4.62
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 4.59
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 4.59
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 4.58
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 4.58
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 4.55
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 4.54
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 4.48
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 4.48
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 4.45
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 4.44
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 4.43
RNA-seq of naive and primed ES cells 4.41
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 4.37
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 4.32
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 4.28
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 4.28
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 4.21
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 4.2
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 4.2
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 4.16
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 4.11
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 4.11
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 4.1
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 4.1
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 4.08
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 4.07
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 4.04
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 4.04
HNF1A deficiency impairs β-cell fate, granule maturation and function 4.02
PRDM1 inhibits proliferation of human colon cancer organoids 3.98
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 3.95
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 3.95
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 3.95
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 3.95
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 3.94
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 3.93
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 3.91
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 3.9
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 3.89
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 3.87
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 3.87
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 3.87
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 3.84
3’ Uridylation Expands miRNA Target Repertoire 3.84
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 3.84
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 3.83
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 3.82
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 3.81
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 3.81
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 3.81
SNHG5 siRNA knock down in HCT116 cells 3.8
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 3.78
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 3.77
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 3.77
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 3.77
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 3.76
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 3.66
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 3.65
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 3.63
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 3.62
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 3.6
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 3.59
Generation and persistence of human tissue-resident memory T cells in lung transplantation 3.58
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 3.58
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 3.57
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 3.57
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 3.56
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 3.53
A Unique Epigenomic Landscape Defines Human Erythropoiesis 3.53
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 3.53
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 3.53
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 3.49
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 3.45
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 3.45
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 3.43
The regulartory role of ZCCHC24 in splicing machinery 3.43
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 3.43
AUF-1 affected genes in human skin cells 3.42
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 3.42
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 3.4
scRNASeq analysis of cycling cardiomyocytes 3.39
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 3.38
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 3.36
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 3.36
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 3.36
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 3.36
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 3.32
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 3.32
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 3.32
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 3.31
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  3.29
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 3.28
Loss of CREBBP results in gene expression repression in lymphoma cells 3.28
High-efficiency RNA-based reprogramming of human primary fibroblasts 3.27
Characterization of human ILC2 subsets 3.27
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 3.27
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 3.25
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 3.24
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 3.23
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 3.21
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 3.2
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 3.2
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 3.19
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 3.19
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 3.18
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 3.18
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 3.18
Co-regulation of splicing by Rbfox1 and hnRNP M 3.16
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 3.16
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 3.15
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 3.15
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 3.15
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 3.14
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 3.14
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 3.14
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 3.12
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 3.12
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 3.11
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 3.1
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 3.09
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 3.09
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 3.09
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 3.08
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 3.08
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 3.08
Chromatin-informed inference of transcriptional programs in gynecologic cancers 3.08
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 3.04
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 3.04
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 3.03
single cell RNA-seq from GM12878 (ENCSR673UIY) 3.02
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 3.01
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 3.01
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 3.01
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 3.0
U1 snRNP telescripting regulates size-function stratified human genome 2.97
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 2.93
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 2.93
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 2.92
RNAseq of cell lines with knocked in ESR1 mutations 2.87
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 2.87
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 2.86
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 2.86
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 2.86
Differential gene expression of human melanoma cells [RNA-seq] 2.86
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 2.81
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 2.8
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 2.8
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 2.79
ARS2 is a general suppressor of pervasive transcription [RNAseq] 2.75
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 2.74
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 2.72
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 2.72
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 2.71
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 2.71
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 2.7
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 2.7
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 2.7
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 2.66
Role of XRN2 ribonucleolytic activity in RNA metabolism 2.64
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 2.61
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 2.6
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 2.6
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 2.59
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 2.58
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 2.57
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 2.57
Functional significance of the HIV-1 Tat signature amino acid residues 2.57
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 2.56
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 2.55
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 2.55
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 2.55
Hepatitis C virus functionally sequesters miR-122 2.55
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 2.53
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 2.5
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 2.5
TAF1 is critical for AE driven leukemogenesis 2.49
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 2.49
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 2.48
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 2.43
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 2.41
RNAseq Study in CC-671 Treated Cal-51 Cells 2.41
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 2.39
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 2.38
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 2.37
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 2.37
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 2.37
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 2.36
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 2.32
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 2.31
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 2.31
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 2.3
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 2.25
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 2.25
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 2.2
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 2.2
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 2.2
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 2.2
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 2.16
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 2.15
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 2.15
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 2.14
RNA-seq of naive and primed ES cells (NHSM) 2.14
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 2.12
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 2.12
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 2.09
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 2.08
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 2.08
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 2.06
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 2.06
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 2.03
HEXIM1 is induced by DHODH inhibition to suppress melanoma 1.97
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 1.97
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 1.96
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 1.96
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 1.95
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 1.9
Biological effect of chronic mistranslation in mammalian cells 1.88
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.86
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.86
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 1.86
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 1.86
Transcriptome of EBV-infected gastric cancer cell lines 1.83
RNA-Seq of PRMT1 overexpression ECA109 cells 1.81
Illumina Total RNA-seq in HeLa 1.75
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 1.72
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 1.72
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 1.67
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 1.67
RNA-seq analysis of differentiating human erythroblasts 1.65
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 1.65
RNA-seq analysis upon ARID1B overexpression 1.63
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 1.62
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.6
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 1.58
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 1.57
Genome-wide discovery of human splicing branchpoints [RNAse] 1.56
Mutational landscape of splicing genes and functional consequences across 33 cancer types 1.56
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 1.54
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 1.53
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 1.5
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 1.49
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 1.49
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 1.49
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 1.48
The transcriptome effect of overexpressing EZH2 in MCF7 1.48
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 1.46
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 1.44
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 1.44
N6-methyladenine DNA Modification in Glioblastoma 1.41
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 1.41
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 1.41
Induction of Cardiomyocyte Proliferation [pz-822_human] 1.39
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 1.39
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.38
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 1.37
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.36
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 1.34
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 1.34
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 1.33
miRNAs affected by antagomiR-17 treatment 1.32
Gene expression changes due to PARP knockdown in human cells 1.31
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 1.31
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 1.31
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 1.29
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 1.29
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 1.26
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 1.26
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 1.23
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 1.22
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 1.22
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 1.21
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 1.21
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 1.21
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 1.2
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 1.19
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 1.17
Differential gene expression profiles in imatinib-resistant cell lines 1.15
Controlling for gene expression changes in transcription factor protein networks. 1.08
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 1.08
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 1.07
UV_24h_GRO-Seq 1.07
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 1.04
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 0.96
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.96
Silencing SPIB in attached and floating state of H1703 lung cancer cells 0.96
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 0.93
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 0.93
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 0.93
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 0.91
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 0.91
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 0.91
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 0.9
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 0.88
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 0.84
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.84
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 0.83
Single-cell analysis of human kidney organoids 0.83
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.82
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.82
Profiling of escape kinetics of viruses subjected to RNAi 0.81
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.81
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.8
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 0.77
Human Treg IFNg/IL-10 subpopulations 0.76
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 0.75
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 0.74
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 0.73
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 0.7
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 0.7
A transcriptome dataset revealing the molecular features of breast cancer stem cells 0.7
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.68
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 0.66
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.64
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.64
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.64
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 0.63
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.63
Comparative Analysis of Cas9 Activators Across Multiple Species 0.62
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 0.61
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.6
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 0.6
Gene expression analysis in response to hypoxic pathway inhibition 0.58
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 0.58
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 0.58
Molecular Criteria for Defining the Naive Human Pluripotent State 0.56
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.54
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 0.54
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.54
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.53
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.52
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.52
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.51
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 0.5
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 0.49
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 0.48
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.48
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 0.45
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 0.42
Copper Regulation of HIF-1 Transcription Activity 0.42
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.4
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.4
Transcriptome sequencing of K-562 cells 0.4
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 0.37
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.37
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 0.37
Impact on erythroid progenitor type on erythroid differntiation 0.36
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.35
Hepatic transcriptome of pediatric hepatoblastoma. 0.34
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.32
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.32
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.31
mRNA recovered upon RNF219 IP. [RNA-IP] 0.31
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.31
H1609088 Human RNA-Sequencing 0.3
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.28
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.28
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.28
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.27
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.27
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.26
quanTIseq: quantifying immune contexture of human tumors 0.26
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.26
Identification of long noncoding RNAs in T-ALL cell lines 0.25
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.25
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 0.23
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 0.23
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.23
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.23
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.23
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.23
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.22
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.22
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 0.21
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.2
Ribosomal protein RPL26 is the principal target of UFMylation 0.18
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.18
Gene expression analysis upon mtDNA depletion 0.18
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 0.16
Leucegene: AML sequencing (part 6) 0.15
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 0.13
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 0.13
RNA seq with AML (NB4) cells upon FTO inhibition 0.12
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.12
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.1
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.1
Regulating Interleukin-2 activity with engineered receptor signaling clamps 0.09
The transcriptome and chromatin accessbility landscape of mammalian germline 0.09
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 0.08
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 0.08
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.08
The circadian transcriptional landscape in primary human mammary epithelial cells 0.07
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.06
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.06
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.03
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.03
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.03
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.02
Function and hormonal regulation of GATA3 in human first trimester placentation 0.01
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation